Law Office of Joseph V. Gibson, P.C.

Law Office of Joseph V. Gibson, P.C.
10330 Lake Road, Building X
Houston, Texas 77070

800.581.4313
281.370.1810
281.370.1811 (fax)

jgibson@jvglaw.com

	Law Office of Joseph V. Gibson
	The Law Office of Joseph V. Gibson, P.C. is dedicated to representing individuals that suffer from severe injuries due to defective products or the negligent conduct of others. We are also dedicated to representing medical professionals and entities that have not been fairly compensated for their services. Our goal is to provide you with aggressive, effective and ethical representation in an effort to provide you with the best results possible. We represent our clients on a contingent fee basis. This means we front all of the expenses for the case. Our clients do not pay anything up front. We only get our expenses back and get paid a fee if we are able to collect on the claim on behalf of our clients. For more information about how we can help you, please contact us for a free case evaluation.
	Current Consumer Cases
	Transvaginal Mesh
	July 13, 2011—Surgeons using transvaginal mesh for repair of pelvic organ prolapse are being cautioned by the FDA to consider other treatment options. Studies have revealed a high failure rate, with about 10 percent of women experiencing erosion of the mesh within one year of surgery. Half of the women who experienced erosion required additional surgery to remove the mesh. The FDA reported that in some of those instances, removal of the mesh was impossible because it had become so intertwined with scar tissue.
	Actos
	The FDA warns that long-term use of Actos may be associated with bladder cancer. A clinical study revealed that patients taking the drug for longer than a year have an increased risk of bladder cancer. The safety information has led Germany and France to ban the sale of the drug, while U.S. regulators continue to assess the drug's safety. The FDA has closely monitored Actos since at least September 2010.
	DePuy ASR Hip Replacement
	August 26, 2010—DePuy Orthopaedics announced it is recalling the ASR XL Acetabular System and ASR Hip Resurfacing System due to a high failure rate. It is estimated that 93,000 of these devices have been implanted worldwide. Since 2008, the FDA has received approximately 400 complaints involving U.S. patients who received the devices. Because only a small percentage of adverse incidents typically are reported to the FDA, the number of people harmed by these defective devices likely is much greater.
	Biomet M2a Magnum Hip Devices
	Since 2009, there has been a significant increase in adverse reports to the FDA involving the Biomet M2A Magnum hip replacement system. In 2009, the FDA received only eleven reports of adverse events associated with this device. The agency received eighty reports in 2011. Adverse events included reports of acetabular cup loosening, metallosis, bone loss, chronic pain, popping or squeaking, metal poisoning and pseudutumors. Because adverse events are underreported to the FDA, it is likely that the number of people harmed by this device is substantially greater.
	Bard IVC Filters
	August 9, 2010—The FDA warned physicians that IVC filters, including those manufactured by C.R. Bard, could fracture, causing serious health comlications. The agency had reviewed 921 adverse event reports since 2005 involving IVC filters. The most common problems involved device migration, detachment of device parts, filter fracture and perforation of the inferior vena cava.
	Our Lawyers Can Help You
	Our lawyers and staff want to help you, in the unfortunate event that you need our help. Just e-mail or telephone us for a free, no obligation, and confidential consultation. For free answers to your legal questions, just complete our convenient online contact form.

Current Consumer Cases

Contact Us

© 2012 by Law Office of Joseph V. Gibson, P.C.